Future of £58m Bristol research centre in question following deal
Plans for a new £58m research centre in Bristol are reportedly in question after an acquisition deal.
Wiltshire inhaler firm Vectura, which was behind the proposals, was snapped up last week by US manufacturer Molex - the parent firm of contract development organisation Phillips Medisize.
It acquired the Chippenham-headquartered respiratory medicines business from tobacco giant Philip Morris International for a knock-down price of £150m ($198m).
The Marlboro cigarette maker announced the sale of Vectura last September, three years after buying the business for more than £1bn. The acquisition deal in 2021 was criticised at the time because Vectura's products are used to treat lung conditions.
In 2022, Vectura was
Recommend
Thompsons of Prudhoe 'thrilled' at 2025 opportunities despite fall in profit and turnover
2025/04/28
2025/04/28
Padel club plans for Peddimore
2025/04/28
2025/04/28
Plans revealed for 33-storey co-living scheme in the centre of Cardiff
2025/04/28
2025/04/28
Business advisory firm FRP opens Bournemouth office
2025/04/28
2025/04/28
Plans for a major public sector hub in Cardiff Bay
2025/04/28
2025/04/28
NG Bailey relocates Leeds headquarters to White Rose Park
2025/04/28
2025/04/28
National law firm to expand into North East in former Newcastle bank site
2025/04/28
2025/04/28
Engineering firm Halton Flamgard expands by taking entire Welsh Government new build unit
2025/04/28
2025/04/28
Business hub to create 45 jobs as plans approved for lorry park
2025/04/28
2025/04/28
Persimmon sees sales rebound and points to higher profit expectations
2025/04/28
2025/04/28
